Platelet-derived microvesicles are involved in cardio-protective effects of remote preconditioning

International Journal of Clinical and Experimental Pathology

Volumn 8, Issue 9, 2015, Pages 10832-10839

  Ma, Fang ^a   Liu, Hengchao ^a   Shen, Yong ^a   Zhang, Yingjie ^a   Pan, Shaojun ^a  

^a BENGBU MEDICAL COLLEGE   (China)

Author keywords

Heart Ischemia reperfusion; Microparticles; Remote ischemia reperfusion preconditioning

Indexed keywords

ANIMAL; BLOOD; BLOOD FLOW; CARDIAC MUSCLE; DISEASE MODEL; HEART CONTRACTION; HINDLIMB; ISCHEMIC PRECONDITIONING; MALE; MEMBRANE MICROPARTICLE; METABOLISM; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; SPRAGUE DAWLEY RAT; THROMBOCYTE; THROMBOCYTE TRANSFUSION; TIME FACTOR; TRANSPLANTATION; VASCULARIZATION;

ANIMALS; BLOOD PLATELETS; CELL-DERIVED MICROPARTICLES; DISEASE MODELS, ANIMAL; HINDLIMB; ISCHEMIC PRECONDITIONING; MALE; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; PLATELET TRANSFUSION; RATS, SPRAGUE-DAWLEY; REGIONAL BLOOD FLOW; TIME FACTORS;

EID: 85012971952     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Przyklenk K and Whittaker P. Remote ischemic preconditioning: current knowledge, unresolved questions, and future priorities. J Cardiovasc Pharmacol Ther 2011; 16: 255-259.
2. Jeanneteau J, Hibert P, Martinez MC, Tual-Chalot S, Tamareille S, Furber A, Andriantsitohaina R and Prunier F. Microparticle release in remote ischemic conditioning mechanism. Am J Physiol Heart Circ Physiol 2012; 303: H871-877.
3. Giricz Z, Varga ZV, Baranyai T, Sipos P, Paloczi K, Kittel A, Buzas EI and Ferdinandy P. Cardioprotection by remote ischemic preconditioning of the rat heart is mediated by extracellular vesicles. J Mol Cell Cardiol 2014; 68: 75-78.
4. Fleming A, Sampey G, Chung MC, Bailey C, van Hoek ML, Kashanchi F and Hakami RM. The carrying pigeons of the cell: exosomes and their role in infectious diseases caused by human pathogens. Pathog Dis 2014; 71: 109-120.
5. Pospichalova V, Svoboda J, Dave Z, Kotrbova A, Kaiser K, Klemova D, Ilkovics L, Hampl A, Crha I, Jandakova E, Minar L, Weinberger V and Bryja V. Simplified protocol for flow cytometry analysis of fluorescently labeled exosomes and microvesicles using dedicated flow cytometer. J Extracell Vesicles 2015; 4: 25530.
6. Hahn CD, Manlhiot C, Schmidt MR, Nielsen TT and Redington AN. Remote ischemic per-conditioning: a novel therapy for acute stroke? Stroke 2011; 42: 2960-2962.
7. Zhu J, Qiu Y, Wang Q, Zhu Y, Hu S, Zheng L, Wang L and Zhang Y. Low dose cyclophosphamide rescues myocardial function from ischemia-reperfusion in rats. Eur J Cardiothorac Surg 2008; 34: 661-666.
8. Lee HB and Blaufox MD. Blood volume in the rat. J Nucl Med 1985; 26: 72-76.
9. Flaumenhaft R, Dilks JR, Richardson J, Alden E, Patel-Hett SR, Battinelli E, Klement GL, Sola-Visner M and Italiano JE Jr. Megakaryocyte-derived microparticles: direct visualization and distinction from platelet-derived microparticles. Blood 2009; 113: 1112-1121.
10. Robert S, Poncelet P, Lacroix R, Arnaud L, Giraudo L, Hauchard A, Sampol J and Dignat-George F. Standardization of platelet-derived microparticle counting using calibrated beads and a Cytomics FC500 routine flow cytometer: a first step towards multicenter studies? J Thromb Haemost 2009; 7: 190-197.
11. Robert S, Lacroix R, Poncelet P, Harhouri K, Bouriche T, Judicone C, Wischhusen J, Arnaud L and Dignat-George F. High-sensitivity flow cytometry provides access to standardized measurement of small-size microparticles brief report. Arterioscler Thromb Vasc Biol 2012; 32: 1054-1058.
12. Rank A, Nieuwland R, Crispin A, Grutzner S, Iberer M, Toth B and Pihusch R. Clearance of platelet microparticles in vivo. Platelets 2011; 22: 111-116.
13. Lai RC, Arslan F, Lee MM, Sze NS, Choo A, Chen TS, Salto-Tellez M, Timmers L, Lee CN, El Oakley RM, Pasterkamp G, de Kleijn DP and Lim SK. Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res 2010; 4: 214-222.
14. Arslan F, Lai RC, Smeets MB, Akeroyd L, Choo A, Aguor EN, Timmers L, van Rijen HV, Doevendans PA, Pasterkamp G, Lim SK and de Kleijn DP. Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury. Stem Cell Res 2013; 10: 301-312.
15. Davidson SM, Hausenloy D, Duchen MR and Yellon DM. Signalling via the reperfusion injury signalling kinase (RISK) pathway links closure of the mitochondrial permeability transition pore to cardioprotection. Int J Biochem Cell Biol 2006; 38: 414-419.